ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 78629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 78629; 2) Community: the network communities that were significantly associated with the response to NSC 78629; 3) Molecule: the relationships between components within communities and NSC 78629; 4) MDR: the compounds that were significantly associated with the NSC 78629.

NSC Compound Enrichment Correlation
NSC 756193 GSK978744A 0.0407060322613561 0.18803982
NSC 762914 6-(4-hydroxy-2-methylphenyl)-2-(4-(methylsulfonyl)phenyl)-4,5-dihydropyridazin-3(2H)-one 0.0407060322613561 0.0043642649
NSC 93077 Null 0.0407060322613564 0.15542746
NSC 9612 Benzo[a]phenazoxonium, 5-(benzylamino)-9-(diethylamino)-, chloride (8CI) 0.0407060322613564 0.084022009
NSC 732851 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene 0.0462077035966078 -0.0077112193
NSC 109451 Null 0.0462077035966084 -0.0045402558
NSC 12097 Resorufine 0.0462077035966084 0.14324499
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0462077035966084 0.2744387
NSC 295501 Camptothecin Derivative 0.0462077035966084 0.0016995953
NSC 623081 Null 0.0462077035966084 0.19772785
Total:49  Current:46    [First] [Prev] [Next] [Last]